Unknown

Dataset Information

0

Vitamin D Supplementation and Prior Oral Poliovirus Vaccination Decrease Odds of COVID-19 Outcomes among Adults Recently Inoculated with Inactivated Poliovirus Vaccine.


ABSTRACT:

Background

Structural and functional commonalities between poliovirus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suggest that poliovirus inoculation may induce antibodies that mitigate the coronavirus disease (COVID-19). No known studies have evaluated COVID-19 risk factors in adults recently vaccinated against poliovirus.

Study objective

Among adults with no history of COVID-19 infection or vaccination, who recently received an inactivated poliovirus vaccine (IPV), we sought to determine which biological factors and social determinants of health (SDOH) may be associated with (1) testing positive for SARS-CoV-2, (2) experiencing COVID-19 symptoms, and (3) a longer duration of COVID-19 symptoms.

Methods

The influence of biological factors and SDOH on SARS-CoV-2 infection and COVID-19 symptoms were evaluated among 282 adults recently inoculated with IPV. Participant-reported surveys were analyzed over 12 months post-enrollment. Bivariate and multivariate linear and logistic regression models identified associations between variables and COVID-19 outcomes.

Results

Adjusting for COVID-19 vaccinations, variants, and other SDOH, secondary analyses revealed that underlying conditions, employment, vitamin D, education, and the oral poliovirus vaccination (OPV) were associated with COVID-19 outcomes. The odds of testing positive for SARS-CoV-2 and experiencing symptoms were significantly reduced among participants who took vitamin D (OR 0.12 and OR 0.09, respectively). Unemployed or part-time working participants were 72% less likely to test positive compared with full-time workers. No prior dose of OPV was one of the strongest predictors of SARS-CoV-2 infection (OR 4.36) and COVID-19 symptoms (OR 6.95).

Conclusions

Findings suggest that prophylactic measures and mucosal immunity may mitigate the risk and severity of COVID-19 outcomes. Larger-scale studies may inform future policies.

SUBMITTER: Comunale BA 

PROVIDER: S-EPMC10892023 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Vitamin D Supplementation and Prior Oral Poliovirus Vaccination Decrease Odds of COVID-19 Outcomes among Adults Recently Inoculated with Inactivated Poliovirus Vaccine.

Comunale Brittany A BA   Hsu Yea-Jen YJ   Larson Robin J RJ   Singh Aditi A   Jackson-Ward Erin E   Engineer Lilly D LD  

Vaccines 20240124 2


<h4>Background</h4>Structural and functional commonalities between poliovirus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suggest that poliovirus inoculation may induce antibodies that mitigate the coronavirus disease (COVID-19). No known studies have evaluated COVID-19 risk factors in adults recently vaccinated against poliovirus.<h4>Study objective</h4>Among adults with no history of COVID-19 infection or vaccination, who recently received an inactivated poliovirus vaccine  ...[more]

Similar Datasets

| S-EPMC10974902 | biostudies-literature
| S-EPMC8030725 | biostudies-literature
| S-EPMC4685687 | biostudies-literature
| S-EPMC3967568 | biostudies-literature
| S-EPMC4504004 | biostudies-literature
| S-EPMC10389671 | biostudies-literature
| S-EPMC4462654 | biostudies-literature
| S-EPMC6200014 | biostudies-literature
| S-EPMC6324442 | biostudies-literature
| S-EPMC9189759 | biostudies-literature